Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E J Lavoie

Showing results (1-10 of 92) with videos related to

Pageof 10
Sort By:
Drug Design and Discovery|February 1, 1994
Prodrugs of hydroxymethylpentamethylmelamine: a principal active metabolite of the antineoplastic agent hexamethylmelamineF Ghodrati, E J Lavoie
The Journal of Organic Chemistry|May 16, 2000
Nitroarylstannanes as synthons for the preparation of phenanthridine and benzo[i]phenanthridine derivativesD Li, B Zhao, E J LaVoie
Japanese Journal of Cancer Research : Gann|February 1, 1987
The carcinogenicity of quinoline and benzoquinolines in newborn CD-1 miceE J LaVoie, A Shigematsu, A Rivenson
Carcinogenesis|September 1, 1983
Identification of the metabolites of benzo[f]quinoline and benzo[h]quinoline formed by rat liver homogenateE J LaVoie, E A Adams, D Hoffmann
Carcinogenesis|January 1, 1982
Identification of metabolites of benzo[b]fluorantheneS Amin, E J LaVoie, S S Hecht
Carcinogenesis|April 1, 1985
On the pharmacokinetics of tobacco-specific N-nitrosamines in Fischer ratsJ D Adams, E J LaVoie, D Hoffmann
Cancer Letters|February 1, 1985
Nicotine: a precursor for carcinogensD Hoffmann, E J Lavoie, S S Hecht
Cancer Letters|October 1, 1984
Fluoranthene and pyrene enhance benzo[a]pyrene--DNA adduct formation in vivo in mouse skinJ E Rice, T J Hosted, E J Lavoie
Chemico-Biological Interactions|January 1, 1987
Identification of metabolites of benzo[j]fluoranthene formed in vitro in rat liver homogenateJ E Rice, N G Geddie, E J Lavoie
Mutation Research|May 1, 1981
Mutagenicity of methylated fluorenes and benzofluorenesE J Lavoie, L Tulley, V Bedenko, et al.
Pageof 10

Showing results (1-10 of 92) with videos related to

Sort By:
Pageof 10
Drug Design and Discovery|February 1, 1994
Prodrugs of hydroxymethylpentamethylmelamine: a principal active metabolite of the antineoplastic agent hexamethylmelamineF Ghodrati, E J Lavoie
The Journal of Organic Chemistry|May 16, 2000
Nitroarylstannanes as synthons for the preparation of phenanthridine and benzo[i]phenanthridine derivativesD Li, B Zhao, E J LaVoie
Japanese Journal of Cancer Research : Gann|February 1, 1987
The carcinogenicity of quinoline and benzoquinolines in newborn CD-1 miceE J LaVoie, A Shigematsu, A Rivenson
Carcinogenesis|September 1, 1983
Identification of the metabolites of benzo[f]quinoline and benzo[h]quinoline formed by rat liver homogenateE J LaVoie, E A Adams, D Hoffmann
Carcinogenesis|January 1, 1982
Identification of metabolites of benzo[b]fluorantheneS Amin, E J LaVoie, S S Hecht
Carcinogenesis|April 1, 1985
On the pharmacokinetics of tobacco-specific N-nitrosamines in Fischer ratsJ D Adams, E J LaVoie, D Hoffmann
Cancer Letters|February 1, 1985
Nicotine: a precursor for carcinogensD Hoffmann, E J Lavoie, S S Hecht
Cancer Letters|October 1, 1984
Fluoranthene and pyrene enhance benzo[a]pyrene--DNA adduct formation in vivo in mouse skinJ E Rice, T J Hosted, E J Lavoie
Chemico-Biological Interactions|January 1, 1987
Identification of metabolites of benzo[j]fluoranthene formed in vitro in rat liver homogenateJ E Rice, N G Geddie, E J Lavoie
Mutation Research|May 1, 1981
Mutagenicity of methylated fluorenes and benzofluorenesE J Lavoie, L Tulley, V Bedenko, et al.
Pageof 10